# Clinical Study of Endocardial Myocardial Biopsy

Study · id `cardio:ct-nct05718128` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05718128](<https://clinicaltrials.gov/study/NCT05718128>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05718128

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT05718128. Allocation not applicable; no masking; primary purpose diagnostic. Start 2021-06-01 (actual); primary completion 2031-06-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Phase 4
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT05718128, source copy `cardio:ctgov-nct05718128-2023-03-28`, retrieved 2026-10-26)
- Started: 2021-06-01 (actual) (ClinicalTrials.gov record NCT05718128, source copy `cardio:ctgov-nct05718128-2023-03-28`, retrieved 2026-10-26)
- Primary completion: 2031-06-01 (anticipated) (ClinicalTrials.gov record NCT05718128, source copy `cardio:ctgov-nct05718128-2023-03-28`, retrieved 2026-10-26)
- Completion: 2031-06-01 (anticipated) (ClinicalTrials.gov record NCT05718128, source copy `cardio:ctgov-nct05718128-2023-03-28`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05718128, source copy `cardio:ctgov-nct05718128-2023-03-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05718128-2023-03-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Study of Endocardial Myocardial Biopsy
- Condition: Myocarditis
- Condition: Cardiomyopathies
- Condition: Heart Failure
- Condition: Cardiac Tumor
- Condition: Endocardiomyocardial Biopsy
- Intervention (Procedure): Endocardiomyocardial biopsy
- Lead sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Cardiomyopathy (heart muscle disease) (`cardio:cardiomyopathy`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine (`cardio:org-second-affiliated-hospital-zhejiang-university-school-of-bfd3ac`)

## Provenance

Content hash: a77312a1ad8b8629e54262bee23af66ba84a2990e0b96c818ad2ed269f8af3f9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
